Zhi-qiang B. Meng
270 Dong An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Implementation of personalized T-cell therapy in the treatment of pancreatic cancer
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: June 25, 2025
Response rates, survival status and adverse events of placebo in randomized control trials for hepatocellular carcinoma: A meta-analysis.
Journal: World journal of hepatology
Published: April 17, 2025
Bufalin Inhibits Tumorigenesis and SREBP-1-Mediated Lipogenesis in Hepatocellular Carcinoma via Modulating the ATP1A1/CA2 Axis.
Journal: The American journal of Chinese medicine
Published: January 19, 2023
Addition of thermal ablation to systemic chemotherapy for the treatment of unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis.
Journal: Expert review of gastroenterology & hepatology
Published: December 23, 2021
Predictive role of the monocyte-to-lymphocyte ratio in advanced hepatocellular carcinoma patients receiving anti-PD-1 therapy.
Journal: Translational cancer research
Published: August 30, 2021
Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: a propensity score matching study.
Journal: Expert review of gastroenterology & hepatology
Published: December 28, 2020
FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
Journal: Cell communication and signaling : CCS
Published: December 28, 2019
CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.
Journal: Aging
Published: June 27, 2019
Second primary malignancy in patients with cholangiocarcinoma: a population-based study.
Journal: Cancer management and research
Published: March 19, 2019
High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells.
Journal: OncoTargets and therapy
Published: March 14, 2019
HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients.
Journal: OncoTargets and therapy
Published: February 19, 2019
Last Updated: 09/26/2026